CymaBay Therapeutics
CBAY
$32.48
Share price
0.00%
Change (1 day)
221.27%
Change (1 year)
Categories
CymaBay Therapeutics (CBAY) Fails to deliver data
Key failure to deliver metrics for CymaBay Therapeutics :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $17.53 M
- Last year FTD volume: $27.14 M
Failures to deliver for CymaBay Therapeutics (CBAY) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for CymaBay Therapeutics (CBAY) - since 2014
Volume in USD (price x number of shares), data since 2014CymaBay Therapeutics (CBAY) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $17.53 M | 37.55% |
| 2023 | $12.75 M | 682.01% |
| 2022 | $1.63 M | -43.37% |
| 2021 | $2.87 M | -80.81% |
| 2020 | $15 M | 1707.76% |
| 2019 | $0.82 M | -82.75% |
| 2018 | $4.81 M | 170.66% |
| 2017 | $1.77 M | 118.41% |
| 2016 | $0.81 M | -79.51% |
| 2015 | $3.97 M | -91.13% |
| 2014 | $44.75 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $16.08 M | $0.32 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | 🇺🇸 USA |
 Xencor XNCR | $0.11 M | $2.13 M | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $2.23 M | $11.74 M | 🇺🇸 USA |